TY  - GEN
AU  - Gaspar,Nathalie
AU  - Occean,Bob-Valéry
AU  - Pacquement,Hélène
AU  - Bompas,Emmanuelle
AU  - Bouvier,Corine
AU  - Brisse,Hervé J
AU  - Castex,Marie-Pierre
AU  - Cheurfa,Nadir
AU  - Corradini,Nadège
AU  - Delaye,Jessy
AU  - Entz-Werlé,Natacha
AU  - Gentet,Jean-Claude
AU  - Italiano,Antoine
AU  - Lervat,Cyril
AU  - Marec-Berard,Perrine
AU  - Mascard,Eric
AU  - Redini,Françoise
AU  - Saumet,Laure
AU  - Schmitt,Claudine
AU  - Tabone,Marie-Dominique
AU  - Verite-Goulard,Cécile
AU  - Le Deley,Marie-Cécile
AU  - Piperno-Neumann,Sophie
AU  - Brugieres,Laurence
TI  - Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study
SN  - 1879-0852
PY  - 2018///0813
KW  - Adolescent
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bone Neoplasms
KW  - drug therapy
KW  - Child
KW  - Child, Preschool
KW  - Cisplatin
KW  - administration & dosage
KW  - Combined Modality Therapy
KW  - Diphosphonates
KW  - Doxorubicin
KW  - Etoposide
KW  - Female
KW  - France
KW  - Humans
KW  - Ifosfamide
KW  - Imidazoles
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Methotrexate
KW  - Neutropenia
KW  - chemically induced
KW  - Osteosarcoma
KW  - Young Adult
KW  - Zoledronic Acid
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ejca.2017.09.036
ER  -